SARS-CoV-2 spike protein: a key target for eliciting persistent neutralizing antibodies

Signal Transduct Target Ther. 2021 Feb 26;6(1):95. doi: 10.1038/s41392-021-00523-5.

Authors

Yang Yang^{1

2

3}, Lanying Du⁴

Affiliations

¹ Roy J. Carver Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA, USA.
² Howard Hughes Medical Institute, Yale University, New Haven, CT, USA.
³ Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA.
⁴ Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, USA. ldu@nybc.org.

No abstract available

Publication types

Research Support, N.I.H., Extramural
Comment

MeSH terms

Antibodies, Neutralizing
COVID-19*
Humans
SARS-CoV-2
Spike Glycoprotein, Coronavirus* / genetics

Substances

Antibodies, Neutralizing
Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2

Grants and funding